The gold price continued to surge to new record highs in the second quarter of the year, reaching an all-time high of C$4,663.85 per ounce, or US$3,433.47, on June 13.…
When the US Food and Drug Administration (FDA) rejected Lykos Therapeutics’ new drug application for MDMA-assisted therapy last August, the initial disappointment cast a shadow over the psychedelics industry. However,…